Compare Genuine Parts Company (GPC) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs GeneDx Holdings Corp — how do they compare? Genuine Parts Company trades at $126.99 (market cap $17.67B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Genuine Parts Company is far larger — about 8.7× GeneDx Holdings Corp's market cap, and Genuine Parts Company pays a 3.32% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and GeneDx Holdings Corp for 19 Days on average.
| GPC | WGS | |
|---|---|---|
Market Cap | $17.67B | $2.02B |
Volume | 1,079,458 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $167.51 |
52-Week Low | $92.47 | $34.51 |
Typical Hold Time | 75 Days | 19 Days |
Enterprise Value | $23.76B | $2.05B |
Dividend Yield | 3.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GPC trades at $127.02, up 1.28% on the day, with a bullish technical signal and analyst consensus price target of $145.75. Recent quarterly earnings show two beats and one miss, while the company prepares for a planned separation of its automotive and industrial units in Q1 2027. Revenue has grown steadily to $24.3B in 2025, but net income margin is thin at 0.13%.
The outlook is supported by the corporate split catalyst and dividend stability, but risks include compressed profitability and rising debt-to-asset ratios. Wall Street sentiment is mixed, with 43% buy ratings, yet the stock offers value with a P/S of 0.71 and exposure to aging vehicle trends.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
